Research Themes

Epidemiology, Kidney Disease, Transplantation

Qualifications

MBBS (distinction) MM(Clin Epid) PhD FRCP(UK) FRACP

Prof Angela Webster

Director, Evidence Integration

Professor Angela Webster is an NHMRC Leadership Fellow. She is a Clinical Epidemiologist, Nephrologist and Transplant Physician, having trained in England, Scotland and Australia. She splits her time working as Director of Evidence Integration at the NHMRC Clinical Trials Centre (CTC), Professor in Clinical Epidemiology in the School of Public Health, and as a Senior Staff Specialist in renal medicine and transplantation at Westmead Hospital.

Angela is closely involved with the international Kidney Disease Improving Global Outcomes (KDIGO) organisation, and is an Editorial Board member of the American Journal of Kidney Disease. She has long standing involvement with Cochrane as an author, editor, and former conflict of interest arbiter. She is Executive Officer of the Australia and New Zealand Islet and Pancreas Transplant Registry, member of the Equity Diversity and Inclusion committee, and past chair and member of the Scientific Programming and Education Committee of the Australian and New Zealand Society of Nephrology (ANZSN). Angela is a member of the governing council of the Transplant Society of Australia and New Zealand (TSANZ) and serves on the National Vigilance and Surveillance Expert Advisory Committee of Australia advising the Organ and Tissue Authority (OTA) on emerging risks identified in the organ and tissue donation and transplantation sectors. She is a member of the Australasian Kidney Trials Network transplant working group.  

Angela is a health services researcher focused on maximising value from existing data and applying best evidence in practice. Themes include multimorbidity and the interaction of chronic diseases, specifically kidney disease, cancer, cardiovascular disease, diabetes, and infection, addressed through evidence integration. Her methodological expertise includes; critical exploration of randomized trial methodology, design and quality in studies of diagnostic and prognostic accuracy, application of advanced statistical concepts in meta-analysis, the manipulation and analysis of large datasets, the methods and application of linkage of large national databases, and design and interpretation of cohort studies. These underpin the themes of better risk communication, shared decision making, and improved health literacy. She has a particular interest in research integrity and biomedical publishing.